DrugPatentWatch Database Preview
Details for Patent: 7,759,308
Which drugs does patent 7,759,308 protect, and when does it expire?
This patent has thirty-seven patent family members in thirty-three countries.
Summary for Patent: 7,759,308
Title: | Microparticles comprising somatostatin analogues |
Abstract: | Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles. |
Inventor(s): | Ahlheim; Markus (Staufen, DE), Ausborn; Michael (Lorrach, DE), Lambert; Olivier (Spechbach-le-Haut, FR), Riemenschnitter; Marc (Freiburg, DE) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 10/579,186 |
Patent Claim Types: see list of patent claims | Compound; Composition; Device; |
Drugs Protected by US Patent 7,759,308
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms Corp | SIGNIFOR LAR | pasireotide pamoate | POWDER;INTRAMUSCULAR | 203255-001 | Dec 15, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
Novartis Pharms Corp | SIGNIFOR LAR | pasireotide pamoate | POWDER;INTRAMUSCULAR | 203255-002 | Dec 15, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
Novartis Pharms Corp | SIGNIFOR LAR | pasireotide pamoate | POWDER;INTRAMUSCULAR | 203255-003 | Dec 15, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 7,759,308
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0326602.0 | Nov 14, 2003 |
United Kingdom | 0406241.0 | Mar 19, 2004 |
PCT Information | |||
PCT Filed | November 12, 2004 | PCT Application Number: | PCT/EP2004/012870 |
PCT Publication Date: | May 26, 2005 | PCT Publication Number: | WO2005/046645 |
Non-Orange Book US Patents Family Members for Patent 7,759,308
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,188,037 | Microparticles comprising somatostatin analogues | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 7,759,308
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 047310 | ➤ Sign Up | |||
Austria | 455537 | ➤ Sign Up | |||
Australia | 2004289055 | ➤ Sign Up | |||
Brazil | PI0416227 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |